146 related articles for article (PubMed ID: 36222555)
1. Prediction of drug-likeness using graph convolutional attention network.
Sun J; Wen M; Wang H; Ruan Y; Yang Q; Kang X; Zhang H; Zhang Z; Lu H
Bioinformatics; 2022 Nov; 38(23):5262-5269. PubMed ID: 36222555
[TBL] [Abstract][Full Text] [Related]
2. Graph Convolutional Capsule Regression (GCCR): A Model for Accelerated Filtering of Novel Potential Candidates for SARS-CoV-2 based on Binding Affinity.
Krishnan A; Vinod D
Curr Comput Aided Drug Des; 2024; 20(1):33-41. PubMed ID: 37005531
[TBL] [Abstract][Full Text] [Related]
3. In-silico pharmacophoric and molecular docking-based drug discovery against the Main Protease (Mpro) of SARS-CoV-2, a causative agent COVID-19.
Haider Z; Subhani MM; Farooq MA; Ishaq M; Khalid M; Akram MN; Khan RSA; Niazi AK
Pak J Pharm Sci; 2020 Nov; 33(6):2697-2705. PubMed ID: 33867348
[TBL] [Abstract][Full Text] [Related]
4. Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases.
Kumari M; Subbarao N
Comput Biol Med; 2021 May; 132():104317. PubMed ID: 33721736
[TBL] [Abstract][Full Text] [Related]
5. Signaling repurposable drug combinations against COVID-19 by developing the heterogeneous deep herb-graph method.
Yang F; Zhang S; Pan W; Yao R; Zhang W; Zhang Y; Wang G; Zhang Q; Cheng Y; Dong J; Ruan C; Cui L; Wu H; Xue F
Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35514205
[TBL] [Abstract][Full Text] [Related]
6. Multiphysical graph neural network (MP-GNN) for COVID-19 drug design.
Li XS; Liu X; Lu L; Hua XS; Chi Y; Xia K
Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35696650
[TBL] [Abstract][Full Text] [Related]
7. Ensembling graph attention networks for human microbe-drug association prediction.
Long Y; Wu M; Liu Y; Kwoh CK; Luo J; Li X
Bioinformatics; 2020 Dec; 36(Suppl_2):i779-i786. PubMed ID: 33381844
[TBL] [Abstract][Full Text] [Related]
8. Drug repositioning of COVID-19 based on mixed graph network and ion channel.
Wang X; Li Q; Liu Y; Du Z; Jin R
Math Biosci Eng; 2022 Jan; 19(4):3269-3284. PubMed ID: 35341251
[TBL] [Abstract][Full Text] [Related]
9. Predicting human microbe-drug associations via graph convolutional network with conditional random field.
Long Y; Wu M; Kwoh CK; Luo J; Li X
Bioinformatics; 2020 Dec; 36(19):4918-4927. PubMed ID: 32597948
[TBL] [Abstract][Full Text] [Related]
10. QSAR Modeling of SARS-CoV M
Alves VM; Bobrowski T; Melo-Filho CC; Korn D; Auerbach S; Schmitt C; Muratov EN; Tropsha A
Mol Inform; 2021 Jan; 40(1):e2000113. PubMed ID: 33405340
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
[TBL] [Abstract][Full Text] [Related]
12. MDGNN: Microbial Drug Prediction Based on Heterogeneous Multi-Attention Graph Neural Network.
Pi J; Jiao P; Zhang Y; Li J
Front Microbiol; 2022; 13():819046. PubMed ID: 35464940
[TBL] [Abstract][Full Text] [Related]
13. Molecular structure, NBO analysis of the hydrogen-bonded interactions, spectroscopic (FT-IR, FT-Raman), drug likeness and molecular docking of the novel anti COVID-2 molecule (2E)-N-methyl-2-[(4-oxo-4H-chromen-3-yl)methylidene]-hydrazinecarbothioamide (Dimer) - quantum chemical approach.
Jenepha Mary SJ; Pradhan S; James C
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Apr; 251():119388. PubMed ID: 33503560
[TBL] [Abstract][Full Text] [Related]
14. Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions.
Peng W; Liu H; Dai W; Yu N; Wang J
Bioinformatics; 2022 Sep; 38(19):4546-4553. PubMed ID: 35997568
[TBL] [Abstract][Full Text] [Related]
15. Molecule generation toward target protein (SARS-CoV-2) using reinforcement learning-based graph neural network via knowledge graph.
Ranjan A; Kumar H; Kumari D; Anand A; Misra R
Netw Model Anal Health Inform Bioinform; 2023; 12(1):13. PubMed ID: 36627927
[TBL] [Abstract][Full Text] [Related]
16. Integrated bioinformatics-cheminformatics approach toward locating pseudo-potential antiviral marine alkaloids against SARS-CoV-2-Mpro.
Swain SS; Singh SR; Sahoo A; Panda PK; Hussain T; Pati S
Proteins; 2022 Sep; 90(9):1617-1633. PubMed ID: 35384056
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous graph inference with matrix completion for computational drug repositioning.
Yang M; Huang L; Xu Y; Lu C; Wang J
Bioinformatics; 2021 Apr; 36(22-23):5456-5464. PubMed ID: 33331887
[TBL] [Abstract][Full Text] [Related]
18. DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations.
Wang J; Liu X; Shen S; Deng L; Liu H
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34571537
[TBL] [Abstract][Full Text] [Related]
19. A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2.
Wang S; Sun Q; Xu Y; Pei J; Lai L
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34081143
[TBL] [Abstract][Full Text] [Related]
20. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
Su X; Hu L; You Z; Hu P; Wang L; Zhao B
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
